ArticleFrontiers in pharmacology2020

Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO.

Pushpendra Goswami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.